Home self-administration of misoprostol for medical abortion up to 56 days' gestation

Journal of Family Planning and Reproductive Health Care

Volumn 31, Issue 3, 2005, Pages 189-192

  Hamoda, Haitham ^a   Ashok, Premila W ^a   Flett, Gillian M M ^a   Templeton, Allan ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COCODAMOL; MIFEPRISTONE; TYLEX;

ARTICLE; BLEEDING; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG SELF ADMINISTRATION; FATIGUE; FEASIBILITY STUDY; FEMALE; GESTATION PERIOD; HEADACHE; HOME CARE; HOT FLUSH; HUMAN; INDUCED ABORTION; NAUSEA; PATIENT PARTICIPATION; SHIVERING; TREATMENT OUTCOME; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; FEASIBILITY STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; PATIENT SATISFACTION; PREGNANCY; SELF ADMINISTRATION;

EID: 22944434145     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1783/1471189054483915     Document Type: Article

References (27)

1. Department of Health. Abortion Statistics, England and Wales, 2002. Department of Health Bulletin 2003/23. London, UK: Department of Health, 2003.
2. Information and Statistics Division (ISD). Abortion Statistics in Scotland 2002. ISD Scotland Health Briefing. Edinburgh, UK: Information and Statistics Division, 2003.
3. Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997; 44: 353-360.
4. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000; 284: 1948-1953.
5. Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000; 61: 41-46.
6. Schaff EA, Eisinger SH, Stadalius LS, Franks P, Gore BZ, Poppema S. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999; 59: 1-6.
7. Pymar HC, Creinin MD, Schwartz JL. Mifepristone followed on the same day by vaginal misoprostol for early abortion. Contraception 2001; 64: 87-92.
8. Robinson HP. Sonar measurement of fetal crown-rump length as means of assessing maturity in the first trimester of pregnancy. BMJ 1973; 4(5883): 28-31.
9. Hamoda H, Critchley HOD, Paterson K, Guthrie K, Rodger M, Penney GC. The acceptability of home medical abortion to women in UK settings. Br J Obstet Gynaecol 2005; 112: 781-785.
10. Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998; 338: 1241-1247.
11. Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 2000; 62: 297-303.
12. Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 2002; 109: 1281-1289.
13. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W, Templeton A. A randomized comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks' gestation. Hum Reprod 2002; 17: 92-98.
14. Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 2004; 69: 51-58.
15. Henshaw RC, Naji SA, Russell IT, Templeton AA. A comparison of medical abortion (using mifepristone and gemeprost) with surgical vacuum aspiration: efficacy and early medical sequelae. Hum Reprod 1994; 9: 2167-2172.
16. Henshaw R, Naji S, Russell I, Templeton A. Psychological responses following medical abortion (using mifepristone and gemeprost) and surgical vacuum aspiration. A patient-centered, partially randomised prospective study. Acta Obstet Gynecol Scand 1994; 73: 812-818.
17. Hamoda H, Ashok PW, Flett GM, Templeton A. Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. Br J Obstet Gynaecol 2004; 111: 996-1000.
18. Howie FL, Henshaw RC, Naji SA, Russell IT, Templeton AA. Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 1997; 104: 829-833.
19. Elul B, Pearlman E, Sorhaindo A, Simonds W, Westhoff C. In-depth interviews with medical abortion clients: thoughts on the method and home administration of misoprostol. J Am Med Womens Assoc 2000; 55(3 Suppl.): 169-172.
20. Fielding SL, Edmunds E, Schaff EA. Having an abortion using mifepristone and home misoprostol: a qualitative analysis of women's experiences. Perspect Sex Reprod Health 2002; 34: 34-40.
21. El Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995; 332: 983-987.
22. Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second-trimester pregnancy. Obstet Gynecol 1997; 90: 735-738.
23. Tang OS, Ho PC. Pilot study on the use of sublingual misoprostol for medical abortion. Contraception 2001; 64: 315-317.
24. Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomized, placebo-controlled trial on the use of mifepristone with sublingual or vaginal misoprostol for medical abortions of less than 9 weeks' gestation. Hum Reprod 2003; 18: 2315-2318.
25. Hamoda H, Ashok PW, Dow J, Flett GMM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days' gestation. Contraception 2003; 68: 335-338.
26. Kiran U, Amin P, Penketh RJ. Self-administration of misoprostol for termination of pregnancy: safety and efficacy. J Obstet Gynaecol 2004; 24: 155-156.
27. Royal College of Obstetricians and Gynaecologists (RCOG). The Care of Women Requesting Induced Abortion. Evidence-based Clinical Guideline No. 7. London, UK: RCOG Press, 2004.